Skip to main content

Table 2 The demographics and characteristics of patients

From: An authoritative algorithm most appropriate for the prediction of pulmonary embolism in patients with AECOPD

Variables

AECOPD(n = 948)

AECOPD-PE(n = 210)

P value

Age-years

66.9 ± 18.6

68.1 ± 20.3

0.858

Age<50-no.(%)

26(2.7)

5(2.4)

0.769

Age ≥ 50-no.(%)

922(97.3)

205(97.6)

 

Female-no.(%)

303(32.0)

72(34.3)

0.515

Male-no.(%)

645(68.0)

138(65.7)

 

Smoker-no.(%)

633(66.8)

145(69.0)

0.525

Nonsmoker-no.(%)

315(33.2)

65(31.0)

 

BODE index

5.9 ± 3.6

6.2 ± 3.4

0.095

D-dimer-ng/ml

1191 ± 676

3118 ± 1635

<0.001

Wells score

3.3 ± 1.4

6.5 ± 3.3

<0.001

DVT sign-no.(%)

96(10.1)

66(31.4)

<0.001

No DVT sign-no.(%)

852(89.9)

144(68.6)

 

PE likely-no.(%)

555(58.5)

177(84.3)

<0.001

PE unlikely-no.(%)

393(41.5)

33(15.7)

 

HR ≤ 100beats/min-no.(%)

450(47.5)

102(48.6)

0.772

HR>100beats/min-no.(%)

498(52.5)

108(51.4)

 

Recent immobilization-no.(%)

640(67.5)

186(88.6)

<0.001

No recent immobilization-no.(%)

308(32.5)

24(11.4)

 

Recent surgery-no.(%)

99(10.4)

45(21.4)

<0.001

No recent surgery-no.(%)

849(89.6)

165(78.6)

 

History of VTE

84(8.9)

21(10.0)

0.603

No history of VTE

864(91.1)

189(90.0)

 

Hemoptysis-no.(%)

66(7.0)

12(5.7)

0.514

No hemoptysis-no.(%)

882(93.0)

198(94.3)

 

Cancer-no.(%)

147(15.5)

54(25.7)

<0.001

No cancer-no.(%)

801(84.5)

156(74.3)

 

SaO2 ≤ 94%-no.(%)

806(85.0)

188(89.5)

0.090

SaO2>94%-no.(%)

142(15.0)

22(10.5)

 

Oral hormone use-no.(%)

275(29.0)

78(37.1)

0.021

No oral hormone use-no.(%)

673(71.0)

132(62.9)

 
  1. AECOPD Acute Exacerbation of Chronic Obstructive Pulmonary Disease, PE Pulmonary Embolism, no. number, BODE Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity, DVT Deep Venous Thrombosis, HR Heart Rate, VTE Venous Thromboembolism, SaO2 Arterial Oxygen Saturation